The dual face of central nervous system tuberculosis: A new Janus Bifrons?

Tuberculosis

Volumn 93, Issue 2, 2013, Pages 130-135

  Sáenz, Brenda ^a   Hernandez Pando, Rogelio ^b   Fragoso, Gladis ^a   Bottasso, Oscar ^c   Cárdenas, Graciela ^d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Laboratorio de Patología Experimental   (Mexico)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^d NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Adaptive response; Central nervous system tuberculosis; Innate response; Tuberculosis

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN FC FRAGMENT; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LAMININ; LECTIN; LIPOARABINOMANNAN; MANNOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PHOSPHATIDYLINOSITOL; PRASTERONE; SCAVENGER; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

APOPTOSIS; BRAIN INFECTION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CHRONIC INFLAMMATION; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IN VITRO STUDY; LEISHMANIASIS; LUNG ALVEOLUS CELL; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; TH1 CELL; TH2 CELL;

ANTITUBERCULAR AGENTS; ENDOCRINE SYSTEM; HUMANS; IMMUNITY, INNATE; LUNG; NEUROIMMUNOMODULATION; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM;

EID: 84875220091     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.11.011     Document Type: Review

References (43)

1. World Health Organization global tuberculosis control: surveillance, planning, financing 2010 WHO
2. G. Cárdenas, and J.L. Soto-Hernández The many faces of central nervous system tuberculosis Arch Neurol 68 2011 1078
3. J. Kleinnijenhuis, M. Oosting, L.A. Joosten, M.G. Netea, and R. Van Crevel Innate immune recognition of Mycobacterium tuberculosis Clin Dev Immunol 2011 2011 405310
4. P.T. Liu, S. Stenger, H. Li, L. Wenzel, B.H. Tan, S.R. Krutzik, M.T. Ochoa, J. Schauber, K. Wu, C. Meinken, D.L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zügel, R.L. Gallo, D. Eisenberg, M. Hewison, B.W. Hollis, J.S. Adams, B.R. Bloom, and R.L. Modlin Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 311 2006 1770 1773
5. H. Saiga, Y. Shimada, and K. Takeda Innate immune effectors in mycobacterial infection Clin Dev Immunol 2011 2011 347594
6. S.M. Behar, M. Divangahi, and H.G. Remold Evasion of innate immunity by Mycobacterium tuberculosis: is death an exits strategy? Nat Rev Microbiol 8 2010 668 674
7. S.K. Pathak, S. Basu, K.K. Basu, A. Banerjee, S. Pathak, A. Bhattacharyya, T. Kaisho, M. Kundu, and J. Basu Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages Nat Immunol 8 2007 610 618
8. S.A. Benson, and J.D. Ernst TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms PLoS One 24 4 2009 e6329
9. R.C. Ryan, M.P. O'Sullivan, and J. Keane Mycobacterium tuberculosis infection induces non-apoptotic cell death of human dendritic cells BMC Microbiol 11 2011 237
10. W.W. Reiley, M.D. Calayag, S.T. Wittmer, J.L. Huntington, J.E. Pearl, J.J. Fountain, C.A. Martino, A.D. Roberts, A.M. Cooper, G.M. Winslow, and D.L. Woodland ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes Proc Natl Acad Sci U S A 105 2008 10961 10966
11. R. Hernandez Pando, D. Aguilar, I. Cohen, M. Guerrero, W. Ribon, P. Acosta, H. Orozco, B. Marquina, C. Salinas, D. Rembao, and C. Espitia Specific bacterial genotypes of mycobacterium tuberculosis cause extensive dissemination and brain infection in an experimental model Tuberculosis (Edinb) 90 2010 268 277
12. V. Guyot-Revol, J.A. Innes, S. Hackforth, T. Hinks, and A. Lalvani Regulatory T-cells are expanded in blood and disease sites in patients with tuberculosis Am J Respir Crit Care Med 173 2006 803 810
13. R. Ribeiro-Rodrigues, T. Resende Co, R. Rojas, Z. Toossi, R. Dietze, W.H. Boom, E. Maciel, and C.S. Hirsch A role for CD4+CD25+T cells in regulation of the immune response during human tuberculosis Clin Exp Immunol 144 2006 25 34
14. X. Chen, B. Zhou, M. Li, Q. Deng, X. Wu, X. Le, C. Wu, N. Larmonier, W. Zhang, H. Zhang, H. Wang, and E. Katsanis CD4(+)CD25(+)FoxP3(+) regulatory T-cells suppress Mycobacterium tuberculosis immunity in patients with active disease Clin Immunol 123 2007 50 59
15. Y. Ozeki, I. Sugawara, T. Udagawa, T. Aoki, M. Osada-Oka, Y. Tateishi, H. Hisaeda, Y. Nishiuchi, N. Harada, K. Kobayashi, and S. Matsumoto Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice Int Immunol 22 2010 179 189
16. J.P. Scott-Browne, S. Shafiani, G. Tucker-Heard, K. Ishida-Tsubota, J.D. Fontenot, A.Y. Rudensky, M.J. Bevan, and K.B. Urdahl Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis J Exp Med 204 2007 2159 2169
17. T. Chiacchio, R. Casetti, O. Butera, V. Vanini, S. Carrara, E. Girardi, D. Di Mitri, L. Battistini, F. Martini, G. Borsellino, and D. Goletti Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis Clin Exp Immunol 156 2009 463 470
18. J.M. Hougardy, V. Verscheure, C. Locht, and F. Mascart In vitro expansion of CD4+CD25high FoxP3+CD127low/-regulatory T-cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans Microbe Infect 9 2007 1325 1332
19. I.J. Suffia, S.K. Reckling, C.A. Piccirillo, R.S. Goldszmid, and Y. Belkaid Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens J Exp Med 203 2006 777 788
20. Y. Belkaid, and K. Tarbell Regulatory T cells in the control of host-microorganism interactions (*) Annu Rev Immunol 27 2009 551 589
21. M.A. Koch, G. Tucker-Heard, N.R. Perdue, J.R. Killebrew, K.B. Urdahl, and D.J. Campbell The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation Nat Immunol 10 2009 595 602
22. H. Liu, M. Komai-Koma, D. Xu, and F.Y. Liew Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells Proc Natl Acad Sci U S A 103 2006 7048 7053
23. H.O. Besedovsky, and A. del Rey Introduction: immune-endocrine network Front Horm Res 29 2002 1 14
24. A.V. Turnbull, and C.L. Rivier Regulation of the hypothalamic-pituitary- adrenal axis by cytokines: actions and mechanism of action Physiol Rev 79 1999 1 71
25. O. Bottasso, M.L. Bay, H. Besedovsky, and A. del Rey The immune-endocrine component in the pathogenesis of tuberculosis Scand J Immunol 66 2007 166 175
26. L. D'Attilio, E. Trini, B. Bongiovanni, G. Dídoli, W. Gardañez, L.J. Nannini, A. Giri, O.A. Bottasso, and M.L. Bay mRNA expression of alpha and beta isoforms of glucocorticoid receptor in peripheral blood mononuclear cells of patients with tuberculosis and its relation with components of the immunoendocrine response Brain Behav Immunol 25 2011 461 467 [Erratum in: Brain Behav Immun. 2012; 26:115]
27. J.S. Dilloin Dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders Curr Drug Targets Inflamm Allergy 4 2005 377 385
28. M.F. Quiroga, M.T. Angerami, N. Santucci, D. Ameri, J.L. Francos, J. Wallach, O. Sued, P. Cahn, H. Salomón, and O. Bottasso Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons PLoS One 7 2012 e33061
29. J.F. Schoeman, G. Fieggen, N. Seller, M. Mendelson, and B. Hartzenberg Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases J Child Neurol 21 2006 301 308
30. V.C. Cheng, W.C. Yam, P.C. Woo, S.K. Lau, I.F. Hung, S.P. Wong, W.C. Cheung, and K.Y. Yuen Risk factors for development of paradoxical response during anti-tuberculous therapy in HIV-negative patients Eur J Clin Microbiol Infect Dis 22 2003 597 602
31. P.R. Antas, L. Ding, J. Hackman, L. Reeves-Hammock, A.K. Shintani, J. Schiffer, S.M. Holland, and T.R. Sterling Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis J Allergy Clin Immunol 117 2006 916 923
32. T.R. Sterling, S.E. Dorman, R.E. Chaisson, L. Ding, J. Hackman, K. Moore, and S.M. Holland Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses Clin Infect Dis 33 2001 976 982
33. D.J. Pepper, S. Marais, G. Maartens, K. Rebe, C. Morroni, M.X. Rangaka, T. Oni, R.J. Wilkinson, and G. Meintjes Neurologic manifestations of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome: a case series Clin Infect Dis 48 2009 e96 e107
34. F. Conradie, A.S. Foulkes, P. Ive, X. Yin, K. Roussos, D.K. Glencross, D. Lawrie, W. Stevens, L.J. Montaner, I. Sanne, and L. Azzoni Natural Killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection J Acquir Immune Defic Syndr 58 2011 309 318
35. L.J. Haddow, O. Dibben, M.Y. Moosa, P. Borrow, and P.J. Easterbrook Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome AIDS 25 2011 1163 1174
36. A.S. de Almeida, C.T. Fiske, T.R. Sterling, and S.A. Kalams Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis Clin Vaccine Immunol 19 2012 45 52
37. L. Tsenova, A. Bergtold, V.H. Freedman, R.A. Young, and G. Kaplan Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system Proc Natl Acad Sci U S A 96 1999 5657 5662
38. T.K. Blackmore, L. Manning, W.J. Taylor, and R.S. Wallis Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes Clin Infect Dis 47 2008 e83 e85
39. G.J. Churchyard, G. Kaplan, D. Fallows, R.S. Wallis, P. Onyebujoh, and G.A. Rook Advances in immunotherapy for tuberculosis treatment Clin Chest Med 30 2009 769 782
40. S. Nadkarni, C. Mauri, and M.R. Ehrenstein Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta J Exp Med 204 2007 33 39
41. S. Sugita, Y. Yamada, S. Kaneko, S. Horie, and M. Mochizuki Induction of regulatory T cells by infliximab in Behcet's disease Invest Ophthalmol Vis Sci 52 2011 476 484
42. O. Aravena, B. Pesce, L. Soto, N. Orrego, F. Sabugo, P. Wurmann, M.C. Molina, J. Alfaro, M. Cuchacovich, J.C. Aguillón, and D. Catalán Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets Immunobiology 216 2011 1256 1263
43. G. Boschetti, S. Nancey, F. Sardi, X. Roblin, B. Flourié, and D. Kaiserlian Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases Inflamm Bowel Dis 17 2011 160 170